In breast cancer, a small study carried out by Smith and colleagues found that both RSK1 and RSK2 expression levels were elevated in ~50% of tumours compared with control cases (n = 12 controls, n = 48 cancers) [31]. Here, RPS6KA3 is linked to cancer.